For NAFLD, GPD1 was linked to CHOLESTEROL_HOMEOSTASIS and E2F_TARGETS (Figure 7A), while MVK was enriched in MYOGENESIS and KRAS_SIGNALING_DN pathways (Figure 7B). Here, GPD1 is linked to metabolic dysfunction-associated steatotic liver disease.